Hospitalization for heart failure occurred in 85 of alogliptin-treated patients versus 79 in the placebo group; however this number did not reach statistical significance [ 43 ].
← all excerpts
The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis.
1
—
—